MINNEAPOLIS, Oct. 26 /PRNewswire/ -- Access Genetics, an Eden Prairie- based molecular diagnostics service company, announced today that it has named industry veteran George M. Hoedeman as its Chief Executive Officer.
Hoedeman brings extensive executive-level experience with medical and high-technology companies, including recent roles as CEO of South Bay Medical, President of the Automation Technology Division of Mentor Corp., Chairman of Wound Care Technologies, and CEO of MicroVision. He is an attorney with eight years of private practice and a CPA, formerly with KPMG. He holds eight issued and pending patents in the medical field.
“We are delighted to attract a CEO of this caliber,” said Dr. Ron McGlennen, President and Medical Director of Access Genetics. “After three consecutive years of nearly 100 percent growth, we will benefit from an experienced guide as we continue this exciting trajectory and embrace the many industry partners who wish to participate with our unique delivery model.”
As CEO, Hoedeman will emphasize the continued development of Access Genetics’ web-based molecular diagnostic services, whereby genetic expertise and ongoing support is brought to partner labs, and assay results may be rapidly interpreted remotely via the internet with expert resources. This unique and highly-successful model currently serves over 35 partner locations across the U.S., located in hospitals, reference laboratories and private pathology groups. A variety of third party assays and equipment are supported.
“The future is bright for the rapidly growing field of molecular diagnostics,” said Hoedeman, “and we expect the web-enabled tools, services and expertise of Access Genetics to be a prime catalyst for this growth.”
Hoedeman holds a B.A. in Accounting from the University of St. Thomas (1977) and received his J.D. from William Mitchell College of Law (1984).
About Access Genetics
Access Genetics is a molecular diagnostics service company offering professional consulting and web-based diagnostic interpretation services. The company assists qualified pathology and clinical laboratories with the implementation and on-going operation of in-house molecular diagnostic programs. Using its telemedicine testing model, Access Genetics enables on-line, real-time interpretations and reporting that assists its partner labs in conducting high-value genetic tests for inherited disorders, infectious diseases, and other panels.
Access Genetics
CONTACT: Terri Poindexter of Access Genetics, +1-952-400-7787,tpoindexter@access-genetics.com
Web site: http://www.access-genetics.com/
